U.S. Knee Implants Market to Grow 6.2% by 2023 | Global Industry Size, Share, Trends and Analysis by Stryker Corporation, DePuy Synthes, Smith & Nephew Plc and B.Braun Melsungen

According to Optima Insights, the U.S.Knee Implants Market is estimated to be valued at US$ XX million in 2017 and is projected to exhibit a CAGR of 6.2% over the forecast period (2019 – 2023).

Key Trends and Analysis of the U.S. Knee Implants Market:

The knee implants market is estimated to increase by 1.4x with the increasing product launches. Forexample, in 2017, Zimmer launched the Persona Partial Knee System in 2017 globally. Further in 2018, the Zimmer also received approval for 510(k) from the U.S. Food and Drug Administration (FDA) for Persona Revision Knee System. Stryker is expected to gain considerable share in the knee implant market with the recent approvals and product launches.

The major restraints of the knee implants market are increase in theproduct alerts and recalls due to device malfunctioning, mislabeling, complaints with infection, swelling and damage to the bone, nerves and muscle near the device.

For Any Queries, Make an Inquiry Here @ https://www.optimainsights.org/categories/orthopedic-spine-trauma-devices

According to the study conducted by OAA,2011,a total of 757,000 knee replacements were performed and in 2010 more than 719,000 knee replacements were performed.By 2013 knee osteoarthritis (OA) contributed for more than $27 billion in the total health care expenditure annually. Nearly 2 millionpeople under 45 years of age and 6 million people between 45 to 64 years and 65 years or older have symptomatic kneeOA.

In 2013, each Total Knee Arthroplasty (TKA) costed around $20,293 and each revision TKA costed around $26,388.It is estimated that 54% of the knee OA would receive total knee replacement over their lifetime and the current trend suggests that there might be a 29% increase in the lifetime direct medical costs attributable to total knee replacement procedure. By 2030 about two in three total knee revision patients will be under 65 years.

Key Market Takeaways:

• The U.S. Knee Implants Market is expected to exhibit a CAGR of 6.2% during the forecast period (2019 - 2023), with the increase in U.S. orthopedic cases requiring knee replacement for either total, partial or revision procedures.

• The most recent advancements in the technology, is paving a way for the success of knee implants. For instance, Conformis recently received U.S. FDA clearance for the only customized, patient specific knee implant.The company creates the customized implants using computed tomography scans and proprietary computer aided design technology.

• A fewkey competitors in the U.S. Knee Implants Market include Stryker Corporation, Zimmer Biomet Holdings, Inc., DePuy Synthes, Smith & Nephew Plc., Exactech Inc., B.Braun Melsungen AG, Allegra Orthopedics Ltd., and Microport Scientific.

Optima Insights has a geographical/regional coverage on five major regions, include, North America, Latin America, Europe, Asia Pacific,and Middle East & Africa. This extensive regional coverage also deep dives into major 26 countries, include, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.

For more details please log on to: www.optimainsights.org

About Optima Insights:

Optima Insights is an innovative research and insights driven enterprise committed to offer actionable intelligence to the global life science and healthcare market players. We believe that meaningful insights and improved strategic content holds the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas to develop targeted research solutions at compelling price point. We continuously support clients through the entire journey map to enable them take better business decisions towards attaining market leadership.

Contact Details:

Chucks G
Director - Global Sales & BD
Optima Insights Pvt. Ltd.,
mail: sales@optimainsights.org
mob: +1 4242554365
www.optimainsights.org

This release was published on openPR.